financetom
Business
financetom
/
Business
/
Grifols' Financial Reports Have No Major Accounting Mistakes, Spanish Regulator Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Grifols' Financial Reports Have No Major Accounting Mistakes, Spanish Regulator Says
Mar 22, 2024 7:13 AM

09:32 AM EDT, 03/22/2024 (MT Newswires) -- Grifols' ( GRFS ) financial reports did not have any significant errors, although these contained deficiencies, Spain's National Securities Market Commission said Thursday in response to a report from short seller Gotham City Research.

There was also no evidence that Grifols ( GRFS ) underreported its leverage as Gotham had alleged, according to the regulator, which reviewed Grifols' ( GRFS ) financial statements. The Gotham report accused the company of deceptive accounting.

The regulator said it found deficiencies related to the EBITDA and debt-to-EBITDA ratios as well as the detail and accuracy of the breakdowns and explanatory notes in some years.

The regulator gave Grifols ( GRFS ) 15 days to publish its commitments to adapt the use of APMs in the next financial reports, as well as a breakdown of its EBITDA and net financial debt for relevant companies where it has non-controlling stakes.

Grifols ( GRFS ) disclosed the regulator's report in a filing Friday.

Shares of the company were down nearly 10% just after the opening bell Friday.

Price: 6.12, Change: -0.66, Percent Change: -9.74

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Johnson Controls International's Sensormatic Solutions, Thruvision Collaborate on Security Screening Technology
Johnson Controls International's Sensormatic Solutions, Thruvision Collaborate on Security Screening Technology
May 29, 2024
10:43 AM EDT, 05/29/2024 (MT Newswires) -- Johnson Controls International's ( JCI ) global retail solutions portfolio Sensormatic Solutions said Wednesday it entered into a partnership with Thruvision. Under the partnership, Thruvision's passive terahertz camera security screening offering will be available on Sensormatic's platform, according to the statement. The technology will provide retailers with a reliable screening option at distribution...
France against Servier selling generics unit Biogaran, PM says
France against Servier selling generics unit Biogaran, PM says
May 29, 2024
PARIS, May 29 (Reuters) - The French government has told drugmaker Servier it is against any sale of its generics subsidiary Biogaran, which has a market share of almost a third in the country, Prime Minister Gabriel Attal said on Wednesday. French media reported last month that Servier had asked potential suitors to file their offers by mid-June. Biogaran is...
Cannae Holdings Insider Sold Shares Worth $499,074, According to a Recent SEC Filing
Cannae Holdings Insider Sold Shares Worth $499,074, According to a Recent SEC Filing
May 29, 2024
10:50 AM EDT, 05/29/2024 (MT Newswires) -- Richard N Massey, Director, on May 24, 2024, sold 25,752 shares in Cannae Holdings ( CNNE ) for $499,074. Following the Form 4 filing with the SEC, Massey has control over a total of 248,615 shares of the company, with 248,615 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1704720/000112760224016756/xslF345X03/form4.xml Price: 18.61, Change: -0.32, Percent Change:...
Why ReShape Lifesciences Stock Is Moving Higher Wednesday
Why ReShape Lifesciences Stock Is Moving Higher Wednesday
May 29, 2024
ReShape Lifesciences, Inc. ( RSLS ) shares are trading higher Wednesday morning following the company’s announcement that it received approval for its patent application. What Happened: On Tuesday after the market close ReShape Lifesciences ( RSLS ) reported that it gained approval from the United States Patent and Trademark Office for its application entitled, “Intragastric Device (For Treating Obesity).” In...
Copyright 2023-2026 - www.financetom.com All Rights Reserved